A Randomized, Open-label, Multiple-dose, Two-arm, One-sequence • Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration Telmisartan/S-amlodipine and Rosuvastatin in Healthy Volunteers

Trial Profile

A Randomized, Open-label, Multiple-dose, Two-arm, One-sequence • Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration Telmisartan/S-amlodipine and Rosuvastatin in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Levamlodipine/telmisartan (Primary) ; Rosuvastatin
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Acronyms CKD-346 DDI P1
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 18 Jun 2014 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea - KCT0001086 ).
    • 16 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top